Skip to main content

OHSU was about to enroll patients in Covid-19 trial suddenly paused by drugmaker

The study was for monoclonal antibodies.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.